Merck partners with Moderna to test KRas cancer vaccines in humans
Thursday, July 5, 2018 - 18:19
in Health & Medicine
The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets